PS ratio:
N/ASummary
- CRSP price to sales ratio is not available.
Performance
CRSP PS ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CRSP PS ratio Trends
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | +1.7% | +1.7% | - |
1 m1 month | - | +26.4% | +26.4% | - |
3 m3 months | - | +24.8% | +25.1% | - |
6 m6 months | - | +18.7% | +19.5% | - |
ytdytd | - | +20.7% | +21.6% | - |
1 y1 year | - | -14.3% | -13.0% | - |
5 y5 years | - | -35.9% | -10.6% | - |
CRSP PS ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | ||||
6 m | 6-month | 129.94 | 94.12 | ||
1 y | 1-year | 129.94 | 94.12 | ||
3 y | 3-year | 10.08K | 5.34 | ||
5 y | 5-year | 28.59K | 3.67 | ||
alltime | all time | 28.59K | 3.67 |
CRSP PS ratio History
Date | Value |
---|---|
2024 | 96.37(+609.6%) |
2023 | 13.58(-99.8%) |
2022 | 7523.51(>+9900.0%) |
2021 | 6.39(-100.0%) |
Date | Value |
---|---|
2020 | 20.84K(>+9900.0%) |
2019 | 12.78(-97.3%) |
2018 | 474.21(+1939.6%) |
2017 | 23.25(-85.1%) |
2016 | 155.83 |
FAQ
- What is the all time high PS ratio for CRISPR Therapeutics AG?
What is the all time high PS ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high price to sales ratio is 28.59K